查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1208611

2023-2030 年膝关节植入物的全球市场

Global Knee Implants Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

膝关节植入物的全球市场规模预计到 2022 年将达到 124.4 亿美元，在预测期内（2023-2030 年）以 4.56% 的复合年增长率增长。

膝关节承重面的手术置换可减轻疼痛和残疾。 这种手术最常被推荐用于其他膝关节疾病，如类风湿性关节炎和银屑病关节炎，以及其他保守治疗无法缓解关节疼痛的情况。 对于患有晚期类风湿性关节炎、外伤或慢性骨关节炎等严重畸形的患者，手术可能会更加困难和危险。 因此，它不能证明全膝关节置换术的合理性。

市场动态

推动全球膝关节植入物市场的主要因素是骨相关疾病和事故发生率的上升，这正在推动市场的繁荣；其中包括全膝关节置换术的普及、膝关节置换术技术的改进、以及由于新兴国家肥胖症的增加，膝关节植入物市场的预期扩张。

骨骼相关疾病和事故发生率的上升正在推动市场繁荣。

根据美国国家医学图书馆的资料，骨折可能是患者骨病的第一个明显迹象，是由骨病（尤其是骨质疏鬆症）引起的主要问题。 据估计，每年有 150 万人因骨病而骨折。 骨质疏鬆症是骨折的最常见原因。 在美国，大约有 1000 万 50 岁以上的人患有髋部骨质疏鬆症。 另有 3360 万 50 岁以上的人髋关节骨量低，通常称为“骨质减少”，使他们面临骨质疏鬆症和未来可能出现并发症的风险。

也很明显，到 2021 年，仅在美国，膝关节置换手术预计每年就会进行约 80 万次。 根据棕榈滩的个性化骨科，这个数字逐年增加。 膝关节置换手术主要是门诊手术，因为手术和骨骼状况推动了膝关节植入物的市场。

世界卫生组织估计，全世界每年有 130 万人死于道路交通事故，另有 20 至 5000 万人遭受非致命伤害。 一半以上的交通死亡事故是由行人、骑自行车的人、摩托车和他们所载的人造成的。 前面提到的变量导致对膝关节植入物的需求增加。

缺乏熟练的外科医生和高成本预计会阻碍市场增长。

骨科手术的高成本和经验丰富的医生的短缺需要市场的改善。

COVID-19 影响分析

COVID-19 流行病导致广泛的手术限制和种植手术取消，导致骨科和医疗器械行业的收入损失惨重。 为了减少交叉感染的机会，医院行业选择了择期手术，限制了被证明对医务人员有潜在风险的手术数量。 由于交叉感染的可能性，大流行期间不得不推迟一些手术。 受疫情影响，膝关节置换市场的就业人数迅速下降，对人们的可支配收入产生了重大影响。

恢復择期膝关节置换服务的一个主要障碍是政府对医疗实践和择期手术的限制和禁令。 此外，在大流行之后，一些医院和门诊服务中心于 2020 年 12 月恢復为患者提供择期关节置换术服务，同时采取了所有必要的安全措施。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 与骨骼相关的疾病和事故的发生率不断增加，推动了市场的繁荣。
      • 人工膝关节手术技术改进
    • 约束因素
      • 骨科手术费用高，经验丰富的医生短缺，需要市场改善
    • 商机
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按类型

  • 全膝关节置换术
  • 部分膝关节置换术
  • 膝关节置换术（修订版）

第 8 章按组件类型

  • 固定膝关节假体 (FBI)
  • 可移动植入物

第 9 章最终用户

  • 医院
  • 门诊手术中心
  • 骨科诊所

第10章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第11章竞争格局

  • 主要发展和战略
  • 公司股票分析
  • 产品基准
  • 值得关注的主要公司名单

第12章公司简介

  • 捷迈邦美
    • 公司简介
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • Corin Group
  • Stryker Corp
  • DePuy Synthes
  • Smith and Nephew
  • Aesculap Implants Systems, LLC
  • Exactech, Inc.
  • MicroPort Scientific
  • CONMED, Kinamed, Inc.
  • ConforMIS

第13章 DataM

简介目录
Product Code: DMMD1528

Market Overview

The global knee implants market size was valued at US$ 12.44 billion in 2022 and is estimated to reach US$ XX million by 2030, growing at a CAGR of 4.56% during the forecast period (2023-2030).

The weight-bearing surfaces of the knee joint are replaced surgically to relieve pain and disability; this procedure is most frequently recommended when other conservative measures are ineffective at reducing joint pain, as well as for other knee diseases like rheumatoid arthritis and psoriatic arthritis. Surgery may be more difficult and risky in patients with significant deformities brought on by advanced rheumatoid arthritis, trauma, or chronic osteoarthritis. Hence it is not a justification for knee replacement surgery.

Market Dynamics

The major factors driving the global knee implants market are the incidence of bone-related diseases and accidents is rising, which is driving the market to flourish, bicruciate-retaining total knee arthroplasty is becoming more popular, improvements in technology for knee replacement surgery and the market for knee implants are anticipated to expand as the number of obese people increases in emerging economies.

The incidence of bone-related diseases and accidents is rising, driving the market to flourish.

According to the National Library of Medicine, U.S., fractures, which could be the first outward sign of bone disease in patients, are the major issue brought on by bone disease, particularly osteoporosis. An estimated 1.5 million people experience a fracture due to a bone condition every year. The most common reason for fractures is osteoporosis. In the U.S., there are about 10 million people over 50 who have hip osteoporosis. An additional 33.6 million people over 50 have low hip bone mass, often known as "osteopenia," putting them at risk for osteoporosis and any potential complications in the future.

And the year 2021 reveals that knee replacement surgery is such a common procedure that it is anticipated to be carried out around 800,000 times annually in the United States alone. That number rises yearly, according to Personalized Orthopedics of the Palm Beaches. Most knee replacements are outpatient procedures due to surgeries and bone conditions boosting the market for knee implants.

The WHO estimates that 1.3 million people die in traffic accidents each year around the world, and another 20 to 50 million people get non-fatal injuries. More over half of all fatalities and injuries caused by traffic accidents involve pedestrians, cyclists, motorcyclists, and the people they are carrying. The previously mentioned variables have led to a rise in the demand for knee implants.

Lack of skilled surgeons and high cost are expected to hamper the market's growth.

The market needs to be improved by the high cost of orthopedic surgeries and the scarcity of experienced doctors.

COVID-19 Impact Analysis

The COVID-19 epidemic resulted in significant revenue losses for the orthopaedic and medical device industries due to widespread surgical restrictions and implant procedure cancellations. The hospital industry chose elective operations by limiting the number of procedures performed, which will prove to be a potential risk for the medical staff, to reduce the likelihood of cross-infection. The potential of cross-infection forced several surgeries to be postponed during the pandemic. The market for knee replacement surgery was severely impacted by the pandemic's quick fall in employment, which impacted people's disposable income.

A major obstacle to restoring elective knee arthroplasty services was the government's limitations and bans on medical procedures and elective surgeries. Additionally, after the pandemic, several hospitals and ambulatory service centers resumed providing elective arthroplasty services to patients in December 2020 while taking all necessary safeguards.

Segment Analysis

The total knee replacement segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The total knee replacement segment is the highest market holder in the global knee implants market Due to the increasing demand for implants and the customized replacement systems provided by businesses, Total Knee Replacement (TKR) is dominating. The considerable patient base of people living with arthritis and the rise in the number of patients receiving the operation are further reasons that contribute to the segment's high proportion of the market. Severe osteoarthritis can be effectively treated with total knee arthroplasty (TKA). TKA results in a good recovery from surgery, good survival rates, and general functional improvement. The main surgical objective continues to be to meet the functional expectations of patients having TKA. Consider total knee replacement surgery if nonsurgical options like medication and using walking aids are no longer effective.

The companies are working consistently to deliver cutting-edge, individualized TKR systems centered on certain patients' requirements. For instance, in December 2021, the first surgery in the U.S. to successfully use Pixee Medical, an FDA-cleared augmented reality surgical application for help in total knee arthroplasty, was completed by MicroPort Orthopedics, a world leader in orthopedic equipment and technologies. Through smart glasses and a unique platform called Knee+ from Pixee Medical, orthopedic surgeons may execute operations more effectively and quickly thanks to real-time instrument positioning. Since 90% of surgeons who use a conventional approach and have never used navigation or robotics find Knee+ intuitive, little training is necessary for them to use it.

In November 2022, the reverse hybrid construct for complete knee arthroplasty, the JOURNEY II ROX Total Knee Solution, was unveiled by Smith+Nephew, a leading medical technology provider worldwide. A new procedural product solution has been developed to give surgeons the therapeutic benefit of cutting-edge bearing material and anatomic design along with the effectiveness and potential long-term tibia fixation of a cementless knee.

Geographical Analysis

North America holds the largest market share in the global knee implants market.

North America dominates the global knee implants market primarily due to its large population, excellent medical infrastructure, and high-income levels. Due to the aging population who need knee replacement surgery, North America has grown to be the largest market. This region's rise has largely been attributed to the top market players' presence there. The people's access to high disposable income has made it possible for them to choose cutting-edge medical techniques that incorporate robot assistance and artificial intelligence.

For instance, in September 2021, Zimmer Biomet acquired FDA 510(k) clearance for the ROSA Hip System for robotically-assisted anterior complete hip replacement in order to broaden its ROSA Robotics portfolio, which already includes the ROSA Knee System for total and partial knee replacement. Additionally, the Persona I.Q., supposedly the first and only smart knee approved by the FDA for total knee replacement, was given a De Novo designation by the FDA so that Zimmer Biomet and Canary Medical may market it.

The increase is the result of several reasons, including an increase in accidents and people with degenerative conditions. For instance, according to a report released in June 2021 by the Canadian Institute for Health Information, approximately 75,073 knee replacements were carried out in Canada year 2020. Additionally, it stated that more than 1.4 billion U.S. dollars are spent annually on knee replacement surgeries in Canada.

Competitive Landscape

The Knee Implants market is moderately competitive with local and global companies' presence. Zimmer Biomet, Corin Group, Stryker Corp, DePuy Synthes, Smith and Nephew, Aesculap Implants Systems, LLC, Exactech, Inc., MicroPort Scientific, CONMED, Kinamed, Inc. ConforMIS .and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, inmARCH 2019, the US-based OMNI Orthopedics, a pioneer in robotic-assisted complete knee replacement, has been acquired by UK international orthopedic corporation Corin Group ("Corin"), funded by the Permira funds..

Smith and Nephew.

Overview: The development, production, and marketing of medical devices for use in orthopaedic reconstruction and trauma, sports medicine, ENT, and advanced wound treatment are the main business activities of Smith & Nephew Plc (Smith & Nephew). The business provides robotics-assisted enabling technologies, trauma products to fix fractures, and knee and hip implants to repair diseased, old, or injured joints.

Product Portfolio:

Genesis II: The GENESIS II Total Knee System has developed into one of the industry's most dependable total knee systems. GENESIS II was built with the most advanced equipment, including the user-friendly MIS system and the ream-through femoral trials, to produce the most complete system..

The global knee implants market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The incidence of bone-related diseases and accidents is rising, driving the market to flourish.
      • 4.1.1.2. Improvements in technology for knee replacement surgery
    • 4.1.2. Restraints:
      • 4.1.2.1. The market needs to be improved by the high cost of orthopedic surgeries and the scarcity of experienced doctors
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis
  • 5.4 Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Total knee replacement
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Partial knee replacement
  • 7.4. Revision knee replacement

8. By Component Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 8.1.2. Market Attractiveness Index, By Component Type
  • 8.2. Fixed-bearing Implants
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Mobile-bearing Implants

9. By End user

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 9.1.2. Market Attractiveness Index, By End user
  • 9.2. Hospitals
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Ambulatory surgical centers
  • 9.4. Orthopedic clinics

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size AnalysisUS$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Products Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. Zimmer Biomet
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Corin Group
  • 12.3. Stryker Corp
  • 12.4. DePuy Synthes
  • 12.5. Smith and Nephew
  • 12.6. Aesculap Implants Systems, LLC
  • 12.7. Exactech, Inc.
  • 12.8. MicroPort Scientific
  • 12.9. CONMED, Kinamed, Inc.
  • 12.10. ConforMIS

LIST NOT EXHAUSTIVE

13. Global Knee Implants Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Application
  • 13.3. Contact Us